Abstract
This paper reviews the existing scientific literature on the relationship between isotretinoin, a vitamin A derivative used to treat severe acne, and the development of depression in patients undergoing treatment. Isotretinoin is highly effective for cases of treatment-resistant acne due to its anti-inflammatory, antibacterial properties, and ability to regulate sebum secretion and keratinization. However, its use is also associated with numerous adverse effects, particularly psychiatric disorders, including depression. The connection between isotretinoin use and the onset of depressive symptoms remains controversial, with studies providing conflicting evidence. This review aims to critically examine the current research to clarify the potential risks of depression associated with isotretinoin.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
